-
Molbio Diagnosti
1,393.10 925.80(%) -
Pine Labs
206.10 283.70(%) -
Larsen & Toubro
3,880.55 3,288.65(%) -
HDFC Bank
708.90 1,020.35(%) -
Power Grid Corpn
268.30 250.05(%) -
ESDS Software
1,716.35 1,716.35(%) -
Trent
2,815.00 3,497.35(%) -
Raymond
1,024.00 1,024.00(%) -
Metro Brands
924.20 883.40(%) -
Reliance Industries
1,253.20 1,250.55(%) -
Billionbrains
200.90 227.00(%) -
Ather Energy
1,615.00 530.65(%) -
One 97
1,829.50 1,829.50(%) -
Hind.Aeronautics
4,861.65 3,479.20(%) -
UPL
567.25 558.00(%) -
HDFC Life Insur.
531.15 796.60(%) -
Bajaj Finance
1,015.40 788.40(%) -
Lodha Developers
1,076.00 650.85(%) -
Dhoot Transmission
1,727.35 1,727.35(%) -
Britannia Inds.
4,946.05 4,946.05(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Divis Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs
- Indian Private
- BSE Code : 21188.0
- ISIN : INE361B01024
-
Today’s Low
9,310.50 -
Today’s High
9,415.00
-
Open
9,370.00 -
Perv Close
9,438.50 -
52W Low
5,636.50 -
52W High
9,615.00
Key Indicators
-
P/E(TTM)
82.64
-
Mar.Cap (₹Cr.)
247,469.81
-
Div & Yield %
0.32
-
Book Value(₹)
629.49
-
Debt-Equity Ratio
-1.23
-
AGM Date
11-Sep-2026
-
EPS
112.85
-
P/E Ratio
82.64
Financials Ratios
-
Debt-Equity Ratio
0.00
-
Mar.Cap (₹Cr.)
247,469.81
-
RONW (%)
12.15
-
ROCE (%)
16.41
Score Board
-
Equity (₹ in Cr.)
53.09
-
BV (₹)
629.50
-
Sales( ₹ in Cr.)
10,388.00
-
NP (in Cr.)
2,662.28
-
NP Var(%)
21.0
-
Div%
1500.0
-
CPS (₹)
117.70
-
EPS (₹)
100.30
-
Traded Value (₹ in Lakhs)
247,576.00
-
52 Week High
9,615.00
-
52 Week Low
5,636.50
-
Price BSE
9326.0
-
Price NSE
9,322.00
-
Market Capital( in Cr.)
247,576.00
-
P/C Ratio
79.30
-
P/E Ratio
93.00
-
Price Vs.BV
100.30
-
01-Aug-2026( 12:48)
Results - Announcements - Divis... - Divis Laboratories Ltd share p...
-
31-Jul-2026( 10:27)
Corporate News - Divi'... - Divi's Laboratories Limited in...
-
31-Jul-2026( 01:00)
Hot Pursuit - Divis... - <p>Divis Laboratories Ltd rose...
-
29-Jul-2026( 01:05)
Hot Pursuit - Divis... - <p>Divis Laboratories Ltd gain...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 10,388.00 | 9,198.00 | 7,665.00 | 7,625.00 | 8,879.82 | 6,798.61 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 10,388.00 | 9,198.00 | 7,665.00 | 7,625.00 | 8,879.82 | 6,798.61 |
| Other Income | 506.00 | 352.00 | 337.00 | 349.00 | 111.26 | 62.53 |
| Stock Adjustments | 244.00 | 83.00 | 127.00 | -50.00 | 449.99 | 100.00 |
| Total Income | 11,138.00 | 9,633.00 | 8,129.00 | 7,924.00 | 9,441.07 | 6,961.14 |
| EXPENDITURE : | ||||||
| Raw Materials | 4,339.00 | 3,827.00 | 3,270.00 | 3,035.00 | 3,499.18 | 2,416.47 |
| Power and Fuel Cost | 530.00 | 465.00 | 477.00 | 496.00 | 390.05 | 319.15 |
| Employee Cost | 1,400.00 | 1,210.00 | 1,067.00 | 953.00 | 926.55 | 808.68 |
| Other Manufacturing Expenses | 325.00 | 276.00 | 299.00 | 285.00 | 255.38 | 202.29 |
| Selling and Administration Expenses | 509.00 | 460.00 | 367.00 | 402.00 | 340.16 | 292.53 |
| Miscellaneous Expenses | 114.00 | 63.00 | 137.00 | 55.00 | 40.95 | 37.69 |
| Employee Benefit Expenses | 1,400.00 | 1,210.00 | 1,067.00 | 953.00 | 926.55 | 808.68 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 7,217.00 | 6,301.00 | 5,617.00 | 5,226.00 | 5,452.27 | 4,076.81 |
| Operating Profit | 3,921.00 | 3,332.00 | 2,512.00 | 2,698.00 | 3,988.80 | 2,884.33 |
| Interest | 24.00 | 2.00 | 4.00 | 2.00 | 1.73 | 1.81 |
| Gross Profit | 3,897.00 | 3,330.00 | 2,508.00 | 2,696.00 | 3,987.07 | 2,882.52 |
| Depreciation | 461.00 | 401.00 | 376.00 | 342.00 | 310.55 | 254.65 |
| Profit Before Tax | 3,436.00 | 2,929.00 | 2,132.00 | 2,354.00 | 3,676.52 | 2,627.87 |
| Current Tax | 869.00 | 793.00 | 511.00 | 438.00 | 637.20 | 609.05 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -40.00 | -73.00 | 45.00 | 108.00 | 90.78 | 64.10 |
| Reported Net Profit | 2,607.00 | 2,209.00 | 1,576.00 | 1,808.00 | 2,948.54 | 1,954.72 |
| Extraordinary Items | -55.28 | 0.00 | 0.74 | 3.07 | -1.65 | -2.45 |
| Adjusted Net Profit | 2,662.28 | 2,209.00 | 1,575.26 | 1,804.93 | 2,950.19 | 1,957.17 |
| Adjustment below Net Profit | 6.00 | -2.00 | -1.00 | 2.00 | 2.18 | 0.16 |
| P & L Balance brought forward | 13,357.00 | 11,725.00 | 10,922.00 | 9,967.00 | 7,588.31 | 5,814.44 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 604.00 | 575.00 | 772.00 | 855.00 | 571.50 | 181.01 |
| P & L Balance carried down | 15,366.00 | 13,357.00 | 11,725.00 | 10,922.00 | 9,967.53 | 7,588.31 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 1,500.00 | 1,500.00 | 1,500.00 | 1,500.00 | 1,500.00 | 1,000.00 |
| Dividend Per Share(Rs) | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 20.00 |
| Earnings Per Share-Unit Curr | 98.38 | 83.36 | 59.47 | 68.23 | 111.08 | 73.64 |
| Earnings Per Share(Adj)-Unit Curr | 98.38 | 83.36 | 59.47 | 68.23 | 111.08 | 73.64 |
| Book Value | 630.60 | 562.08 | 508.83 | 479.43 | 440.44 | 349.28 |
| Book Value(Adj)-Unit Curr | 630.60 | 562.08 | 508.83 | 479.43 | 440.44 | 349.28 |
